Skip to content

GlobalRPh Renal Dosing Master v6.6

Find renal guidance

Drug names first. Optional full-text search.

Find a renal dosing reference

Each letter includes generic and brand-name matches. Choosing a letter clears earlier filters. Brands are cross-references, not extra drug records.

Add a medication list for quick renal review General renal statements Compare source differences

Product-specific addition

Ponesimod - PONVORY tablets

PONVORY / Ponesimod

Local RX List renal extract. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 11 difference / caution notes

Open renal guidance Evidence sources

Product-specific addition

Posaconazole delayed-release tablets (adult prophylaxis)

Noxafil delayed-release tablets

Local official-label summary. Read the exact source scope and cautions.

Label: 1Professional: 1Handbook: 0RX List: 0

Open renal guidance Evidence sources

Product-specific addition

Potassium chloride premix (KCL in D5NS)

KCL in D5NS

Local RX List renal extract. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 1

Open renal guidance Evidence sources

Product-specific addition

Potassium chloride premix (KCL in D5W)

KCL in D5W

Local RX List renal extract. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 1

Open renal guidance Evidence sources

Product-specific addition

Potassium chloride premix (KCL in NS)

KCL in NS

Local RX List renal extract. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 1

Open renal guidance Evidence sources

General renal statement

Potassium chloride tablets/capsules

GlobalRPh general statement. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 0

Open renal guidance Evidence sources

Product-specific addition

Potassium citrate ER (UROCIT-K)

Urocit-K

Local RX List renal extract. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 11 difference / caution notes

Open renal guidance Evidence sources

Product-specific addition

Potassium/sodium phosphate tablets (K-PHOS NEUTRAL)

K-PHOS NEUTRAL

Local RX List renal extract. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 11 difference / caution notes

Open renal guidance Evidence sources

Product-specific addition

Pralatrexate injection (FOLOTYN)

FOLOTYN / Pralatrexate

Local RX List renal extract. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 21 difference / caution notes

Open renal guidance Evidence sources

Product-specific addition

Pralsetinib - GAVRETO capsules

GAVRETO / Pralsetinib

Local RX List renal extract. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 11 difference / caution notes

Open renal guidance Evidence sources

Product-specific addition

Pramipexole - immediate-release tablets

PRAMIPEXOLE IR / Pramipexole

Local official-label summary. Read the exact source scope and cautions.

Label: 1Professional: 0Handbook: 0RX List: 01 difference / caution notes

Open renal guidance Evidence sources

Product-specific addition

Pramipexole extended-release (MIRAPEX ER)

Mirapex ER / MIRAPEX ER / Pramipexole

Local RX List renal extract. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 22 difference / caution notes

Open renal guidance Evidence sources

GlobalRPh renal entry

Pravastatin

GlobalRPh source page. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 0

Open renal guidance Evidence sources

GlobalRPh renal entry

Pregabalin - immediate release

LYRICA

Local official-label summary. Read the exact source scope and cautions.

Label: 1Professional: 0Handbook: 0RX List: 11 difference / caution notes

Open renal guidance Evidence sources

Product-specific addition

Pregabalin - LYRICA CR extended release

LYRICA CR / Pregabalin

Local RX List renal extract. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 11 difference / caution notes

Open renal guidance Evidence sources

Product-specific addition

Pretomanid - tablets in a combination tuberculosis regimen

PRETOMANID / Pretomanid

Local RX List renal extract. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 11 difference / caution notes

Open renal guidance Evidence sources

GlobalRPh renal entry

Primidone

GlobalRPh source page. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 0

Open renal guidance Evidence sources

GlobalRPh renal entry

Propoxyphene

GlobalRPh source page. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 0

Open renal guidance Evidence sources

Product-specific addition

Propranolol oral solution for infantile hemangioma - HEMANGEOL

HEMANGEOL

Local RX List renal extract. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 1

Open renal guidance Evidence sources

Product-specific addition

Prucalopride - MOTEGRITY official label

MOTEGRITY / Prucalopride

Local official-label summary. Read the exact source scope and cautions.

Label: 1Professional: 0Handbook: 0RX List: 01 difference / caution notes

Open renal guidance Evidence sources

GlobalRPh renal entry

Pyrazinamide

GlobalRPh source page. Read the exact source scope and cautions.

Label: 0Professional: 2Handbook: 0RX List: 0

Open renal guidance Evidence sources

Product-specific addition

Pyridostigmine - MESTINON oral products

MESTINON / Pyridostigmine

Local RX List renal extract. Read the exact source scope and cautions.

Label: 0Professional: 0Handbook: 0RX List: 11 difference / caution notes

Open renal guidance Evidence sources

Keep the source and the patient context together

1. Choose the exact product

Generic names and brands can lead to different formulations. Select the matching route and release type.

2. Read a whole source

Renal tables retain their indication, units and dialysis assumptions. Do not combine doses and intervals from different protocols.

3. Check the limits

Read source qualifications, monitoring and interactions. A missing dose or absent result does not mean no adjustment.

How to use this reference

What is included, and what is still missing?

945 product/formulation records and 747 selected RX summaries are local. All 26 directory attempt logs exist; full monograph and independent clinical review remain open.

Open the missing-content inventory